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To examine the prevalence rates and correlates of  non-medical use of
prescription stimulants (Ritalin, Dexedrine or Adderall) among US college stu-








One hundred and nineteen nationally representative 4-year colleges









Self-reports of  non-medical use of  prescription stimulants and




The life-time prevalence of  non-medical prescription stimulant use
was 6.9%, past year prevalence was 4.1% and past month prevalence was
2.1%. Past year rates of  non-medical use ranged from zero to 25% at individual
colleges. Multivariate regression analyses indicated non-medical use was
higher among college students who were male, white, members of  fraternities
and sororities and earned lower grade point averages. Rates were higher at
colleges located in the north-eastern region of  the US and colleges with more
competitive admission standards. Non-medical prescription stimulant users
were more likely to report use of  alcohol, cigarettes, marijuana, ecstasy, cocaine




The findings of  the present study provide evidence that non-
medical use of  prescription stimulants is more prevalent among particular sub-
groups of  US college students and types of  colleges. The non-medical use of  pre-
scription stimulants represents a high-risk behavior that should be monitored
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Methylphenidate, dextroamphetamine and mixed-salts
amphetamine are considered first-line pharmacotherapy
for the treatment of  attention deficit hyperactivity




. 2002). Brand names
for these compounds include Ritalin, Dexedrine and
Adderall, respectively. Several studies have reported
recent increases in the prescribing of  psychoactive medi-









2003), including amphetamines and other stimulant








. 2003). The rise in these medical prescriptions is due
to several factors, including an increased awareness
 












regarding the signs and symptoms of  certain disorders




. 1998) and an increased
duration of  treatment (Safer, Zito & Fine 1996). In order
to put these increased US rates of  prescription stimulants
into an international perspective, it is important to rec-
ognize that the use of  prescription stimulants, such as
methylphenidate, is higher in the United States than in




. 2002). Indeed, the United
States consumes a majority of  the world’s supply of  meth-
ylphenidate (Woodworth 2000). The prevalence of  the
ADHD diagnosis is also higher in the United States than
in other countries (Popper & West 1999). Furthermore,
increases in the use of  prescription psychostimulants,
such as methylphenidate, have occurred in countries out-





implications of  this increased use of  prescription stimu-
lants remain to be determined.
Despite the efficacy of  prescription stimulants for treat-
ing symptoms of  ADHD, the increase in prescription rates
has raised some public health concerns because of  the
abuse potential of  these medications (Kollins, MacDonald
& Rush 2001) and the evidence that the non-medical use
of  prescription stimulants represents a problem among
young adults in general (Office of  Applied Studies 2003;
SAMHSA 2003a, 2003b) and among college students in
particular (Babcock & Byrne 2000; Johnston, O’Malley &




. 2003). National epi-





 2003a, 2003b), national surveil-
lance reports (SAMHSA 2003a, 2003b) and college-





2003; McCabe, Teter & Boyd in press) provide strong evi-
dence that the non-medical use of  prescription stimulants
is a growing problem among young adults and college
students in the United States. The Monitoring the Future
Study (MTF) found that college students (5.7%) reported
higher rates of  non-medical use of  methylphenidate
(Ritalin) than their same-age peers not attending college





Several studies have examined the non-medical use
of  prescription stimulants at individual US colleges or
universities using random sampling (e.g. Babcock &









Collectively, these college-based studies suggest that
there may be variation in the non-medical prevalence
rate of  prescription stimulants across different types of
colleges. Although these single institutional studies pro-
vide valuable information, they provide only a partial
picture of  the spectrum of  non-medical use of  prescrip-
tion stimulants on college campuses in the United
States. We could find no studies that have examined the
prevalence and correlates of  non-medical use of  pre-
scription stimulants among a national sample of  college
students.
The main aims of  the present study were to assess the
prevalence of  non-medical prescription stimulant use
(Ritalin, Dexedrine or Adderall) within a large national
sample of  randomly selected students attending 4-year
colleges and to determine the correlates of  non-medical
use in terms of  demographic characteristics, institutional




The present study used data from the 2001 College Alco-
hol Study (CAS) survey of  119 American 4-year colleges
and universities in 39 states. An administrator from each
college or university provided a list of  215 randomly
selected college students. One school was excluded
because the response rate was considerably lower than
the other 119 schools. A total of  10 904 students
returned questionnaires, yielding an overall response rate
of  approximately 52% (range 22–86%). Response rate
was not associated with the main outcome variable (i.e.
the Pearson correlation coefficient between the non-med-
ical use of  stimulant medication and the response rate at








 0.19). Consistent with previous studies, the data were
weighted based on gender, age and ethnicity in order to be
more representative of  each school. Study design and pro-





The final sample of  119 colleges represented a
national cross-section of  students enrolled at 4-year col-
leges in the United States. Sixty-nine per cent of  students
in the CAS sample attended public institutions and 31%
attended private institutions, which closely resembles
the US national distribution of  68% and 32%, respec-
tively, for full-time, 4-year college students. Sixty-nine
per cent of  students in the CAS sample attended schools
in medium- to large-sized cities and 31% attended col-
leges in small towns and rural areas, which approxi-
mates the US national distribution of  71% and 29%,
respectively. Eighty-seven per cent of  students in the CAS
sample attended non-religiously affiliated colleges and
13% attended religiously affiliated schools compared to
84% and 16% of  full-time, 4-year college students
nation-wide. In addition, 47% of  students in the CAS





23% medium-sized institutions (5001–10 000 students)
and 29% small institutions (1000–5000 students).
Twenty-three per cent of  students in the CAS sample
attended schools located in the North-east, 29% in the
South, 30% in the North Central and 18% in the West.
Finally, 5% of  students in the CAS sample attended
women’s colleges and 2% attended historically black col-
leges and universities.
 














The questionnaire and measures
 
Students completed a 20-page survey, which contained
questions regarding demographic characteristics, sub-
stance use and other health behaviors.
 
Non-medical use of  prescription stimulants
 
Respondents were asked ‘How often, if  ever, have you
used any of  the drugs listed below? Do not include any-
thing you used under a doctor’s orders.’ Drug items
included ‘Ritalin, Dexedrine or Adderall.’ The response
scale was (1) never used; (2) used, but not in the past
12 months; (3) used, but not in the past 30 days; and (4)




Respondents were asked ‘How often, if  ever, have you
used any of  the drugs listed below? Do not include any-
thing you used under a doctor’s orders.’ Drug items
included each of  the following: ‘marijuana, crack
cocaine, other forms of  cocaine, ecstasy (MDMA) and opi-
ate-type prescription drugs (e.g. codeine, morphine,
Demerol, Percodan, Percocet, Vicodin, Darvon, Darvo-
cet).’ The response scale ranged from (1) never used to (4)




Respondents were asked ‘How often, if  ever, have you
used any of  the drugs listed below? Do not include any-
thing you used under a doctor’s orders.’ Drug items
included ‘cigarettes.’ The response scale ranged from (1)




Heavy episodic drinking (or binge drinking) was defined
as the consumption of  at least five drinks in a row for men
and at least four drinks in a row for women during the 2





. 1995). ‘Frequent binge drinking’ was defined as
having three or more binge drinking episodes in the past
2 weeks. ‘Drink to get drunk’ was assessed with one item
that asked students whether drinking ‘to get drunk’ was




Data analysis included 10 904 undergraduate student
respondents from 119 institutions. Statistical analyses
were carried out using procedures available in the Stata
software package for analysis of  complex sample survey
data (StataCorp 2001). Data were weighted to account
for colleges’ varying sampling fractions. We used contin-
gency tables to present the prevalence estimates of  non-
medical use of  prescription stimulants in terms of  student
and college characteristics. Differences among the prev-
alence of  non-medical use between student and college













 tests were conducted for the following individual-level
characteristics (gender, race, Hispanic ethnicity, age, liv-
ing arrangement, fraternity/sorority membership, grade
point average, father’s level of  education, mother’s level of
education) and college-level characteristics (admissions
selectivity, public versus private college, geographical
region, commuter status, co-educational status, size of
school enrollment, urbanization). Multiple logistic
regressions accounting for the complex design of  the
sample were used to predict the student level outcomes of
past year and past month non-medical use of  prescription
stimulants, while controlling for the individual-level and
college-level characteristics that were significantly asso-
ciated with either past year or past month non-medical







 0.01). Odds ratios were adjusted for gender,
race, age, living arrangement, fraternity and sorority
membership status, grade point average, mother’s educa-
tional level, father’s educational level, admissions selec-
tivity, geographical region and commuter status; 95%
confidence intervals (CI) were reported for the odds
ratios. Interactions between college-level and individual-
level characteristics were examined in the logistic regres-
sion models in order to investigate whether the relation-
ships of  individual-level characteristics with non-medical
use of  prescription stimulants varied by college-level
characteristics. A similar multivariate approach was used
to examine the relationship of  non-medical use of  pre-
scription stimulants with the likelihood of  engaging in
various substance use behaviors, adjusting for other fac-
tors. We used stata to obtain correct standard errors of
the estimated regression coefficients accounting for the




Prevalence of  non-medical use of  prescription stimulants 
by student characteristics
 




 0.005) of  college students
reported life-time non-medical use of  prescription stimu-




 0.004) reported non-medical use in the




 0.002) reported past month
use. As illustrated in Table 1, the past year and past
month prevalence of  non-medical use of  prescription
 












stimulants differed significantly as a function of  several
student characteristics including gender, race/ethnicity,
age, living arrangement, fraternity/sorority membership,
grade point average and parental level of  education.
 
Prevalence of  non-medical use of  prescription stimulants 
by college characteristics
 
There was a great deal of  variation across campuses with
respect to the non-medical use of  prescription stimulants.
As illustrated in Fig. 1, the aggregate past year
prevalence rates of  non-medical use at individual colleges
ranged from 0% to 25%, with 20 schools having a prev-
alence of  0% and 12 schools having a prevalence of  10%
or higher. Based on the overall past year prevalence of
4.1% and an average college sample size of  90, the stan-
dard error at the typical/average college was approxi-
mately 2%. The past month prevalence rates of  non-
medical use at individual colleges ranged from 0% to
13%.
As illustrated in Table 2, the prevalence of  past















































Male 3868 5.8 (4.6, 7.2) 2.8 (2.2, 3.7)
Race













African American 787 1.6 (0.6, 4.2) 0.4 (0.1, 1.3)
Asian 835 1.3 (0.7, 2.6) 0.7 (0.2, 2.0)
Other 938 3.1 (1.9, 4.9) 2.0 (0.1, 3.4)
Age (years)









21–23 3959 4.5 (3.6, 5.6) 2.1 (1.5, 2.8)
24 or older 1438 1.6 (0.9, 2.6) 0.7 (0.3, 1.7)
Living arrangement









Co-ed residence hall 2543 4.5 (3.3, 6.2) 2.5 (1.8, 3.5)
Other university housing 399 4.0 (2.3, 6.8) 1.8 (0.7, 4.4)
Fraternity/sorority house 267 13.3 (7.8, 21.8) 8.0 (4.7, 13.3)
Off  campus house or apartment 6241 3.7 (2.9, 4.6) 1.8 (1.3, 2.3)
Fraternity/sorority membership









Member 1331 8.6 (6.2, 11.8) 4.7 (3.2, 6.7)
Grade point average













 or higher 6179 3.3 (2.6, 4.1) 1.7 (1.3, 2.2)
Father’s level of  education









High school diploma 1921 2.5 (1.7, 3.6) 0.9 (0.1, 1.7)
Some college 2742 3.0 (2.3, 3.9) 1.4 (0.1, 2.0)
Four year college degree or more 5185 5.7 (4.6, 7.1) 3.1 (2.4, 3.9)
Don’t know 144 1.5 (0.5, 4.7) 1.5 (0.1, 4.7)
Not applicable 146 3.6 (0.9, 13.2) 3.0 (0.1, 13.7)
Mother’s level of  education









High school diploma 2382 3.1 (2.2, 4.3) 1.5 (0.9, 2.3)
Some college 3193 3.5 (2.7, 4.5) 1.7 (1.2, 2.3)
Four year college degree or more 4514 5.5 (4.3, 6.9) 3.0 (2.3, 3.9)
























 0.01) associated with either past year or past month non-medical use of  prescription stimulants are not shown and included Hispanic
ethnicity.
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stimulants differed significantly as a function of  admis-
sions selectivity, commuter status and geographical
region (past year only). For example, more than 80% of
the colleges with an aggregate past year prevalence rate
of  10% or higher had highly competitive admissions stan-
dards and were located either in the North-east or South-
ern regions of  the United States. In addition, among all
students attending three historically black colleges in the
sample, there were no students who reported non-




As illustrated in Table 3, logistic regression analyses con-
firmed that past year and past month non-medical use
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Competitive 71 6375 4.5 (3.6, 5.7) 2.3 (1.7, 3.0)
Most competitive 22 2177 5.9 (4.0, 8.5) 3.1 (2.1, 4.4)
Geographical region









South 37 3162 4.6 (3.3, 6.3) 2.7 (2.0, 3.7)
North Central 33 3208 2.8 (2.1, 3.8) 1.3 (0.9, 1.8)
West 20 1926 3.2 (1.9, 5.4) 1.5 (0.8, 3.1)
Commuter status
























 0.01) associated with either past year or past month non-medical use of  prescription stimulants are not shown and included public versus
private college status, co-educational status, size of  school enrollment and urbanization.
 












students who were male, white, members of  fraternities
and sororities, had lower grade point averages, attended
colleges located in the North-eastern region of  the United
States and attended more selective colleges (past year
only). Specifically, after adjusting for other factors, college
men were almost two times more likely than women to
report non-medical use of  prescription stimulants. In
addition, white students were more likely than Asian and
African American students to report non-medical use.
Fraternity and sorority members were over two times
more likely than non-members to report non-medical use
of  prescription stimulants. Students who earned a B or
lower grade point average were almost two times more
likely to report non-medical use compared to students




 or higher. In terms of  college character-
istics, students attending colleges located in the North-
eastern region of  the United States were more likely to
report non-medical use than students attending colleges
located in North Central region of  the United States.
Finally, students who attended colleges with competitive
or highly competitive admissions criteria were over two
times more likely than students who attended less com-
petitive colleges to report past year non-medical use of
prescription stimulants.
Interactions between college-level and individual-
level characteristics were examined in the multiple logis-
tic regression models in order to investigate whether the
relationships of  individual-level risk factors that signifi-
cantly predicted non-medical use of  prescription stimu-
lants in Table 3 varied by college-level characteristics
(results not shown). There were no significant interac-
tions for past month non-medical use and only one sig-
nificant interaction was found for past year non-medical
use. In particular, attending college in the North Central
United States served as a stronger risk factor for non-
members of  fraternities and sororities relative to members







Interactions between individual-level characteristics
were also examined and very few were found. There were
no significant interactions for past month non-medical
use and only one statistically significant interaction was
found for past year non-medical use. Being African
American served as a stronger risk factor for past year

























Female – – – –
Male 1.92*** (1.49, 2.48) 1.66*** (1.24, 2.21)
Race
White – – – –
African American 0.39 (0.15, 1.07) 0.18** (0.05, 0.62)
Asian 0.26*** (0.13, 0.52) 0.30* (0.10, 0.92)
Other 0.75 (0.47, 1.20) 1.03 (0.60, 1.67)
Fraternity/sorority membership
Non-member – – – –
Member 2.07*** (1.38, 3.09) 2.04** (1.21, 3.45)
Grade point average





 or higher 0.54*** (0.42, 0.70) 0.57*** (0.42, 0.78)
Admission criteria
Less competitive – – – –
Competitive 2.29** (1.34, 3.91) 1.88 (0.95, 3.71)
Most competitive 2.57** (1.36, 4.84) 2.06 (0.98, 4.34)
Geographical region
North-east – – – –
South 0.68 (0.42, 1.09) 0.86 (0.54, 1.39)
North Central 0.46** (0.30, 0.72) 0.44** (0.26, 0.72)
































Odds ratios are adjusted for all predictors
in both models, which included gender, race, age, living arrangement, mother’s level of  education, father’s level of  education, fraternity and sorority







 0.01) associated with either past year or past month non-medical use of  prescription stimulants are not shown and included age, living
arrangement, mother’s level of  educational level, father’s level of  education and commuter status.
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The relationship of  non-medical use of  prescription 
stimulants to other substance use
 
As illustrated in Table 4, non-medical use of  prescription
stimulants was highly related to substance use and other
risky behaviors after adjusting for the same factors in
Table 3. For instance, past year non-medical prescription
stimulant users were ten times more likely to report mar-
ijuana use in the past year, almost seven times more likely
to report frequent binge drinking, over 20 times more
likely to report cocaine use in the past year, and over five
times more likely to report driving after binge drinking
than college students who had not used prescription
stimulants non-medically. Results were similar for the
relationship between past month non-medical use and
other drug use (results not shown).
At the college-level of  analysis, the correlation of  non-
medical prescription stimulant use and substance use at
the 119 colleges and universities was examined. The cor-
relation between a school’s past year aggregate rate of
non-medical use of  prescription stimulants and mari-















correlation between a school’s past year aggregate level of
non-medical use of  prescription stimulants and aggregate
level of  binge drinking was r = 0.52 (P < 0.001). Finally,
college campuses with high (over 50%) or medium (36–
50%) aggregate levels of  binge drinking had significantly
higher past year aggregate rates of  non-medical prescrip-
tion stimulant use than schools with lower (35% or less)
aggregate levels of  binge drinking (6%, 5% and 1%,
respectively, P < 0.001).
DISCUSSION
The present study found that the population of  US col-
lege students reporting life-time non-medical use of  pre-
scription stimulants was 6.9%, past year use was 4.1%
and past month use was 2.1%. These prevalence rates
are similar to recent rates from other national studies of
college students (e.g. Johnston et al. 2003a) and young
adults (Office of  Applied Studies 2002a, 2002b). Non-
medical prescription stimulant use was higher among
certain types of  college students, in particular among
men, white students, members of  fraternities and sorori-
ties and those with lower grade point averages. Collec-
tively, many of  these individual-level characteristics
have been shown previously to be associated with
higher rates of  substance use among American college






(n = 10 399)
% (95% CI) Adjusted ORb,c 95% CI
Tobacco and alcohol use
Cigarette use in the past 30 days 66.7 (61.7, 71.4) 23.6 (22.0, 25.2) 6.15*** (4.88, 7.76)
Frequent binge drinking 69.4 (63.0, 75.1) 20.6 (18.7, 22.6) 6.75*** (5.01, 9.08)
Drink to get drunk 80.8 (76.2, 84.7) 46.8 (44.7, 49.0) 3.79*** (2.85, 5.04)
Drug use in the past 30 days
Marijuana 67.8 (62.5, 72.8) 14.6 (13.4, 15.8) 10.59*** (8.16, 13.73)
Ecstasy 18.9 (14.5, 24.3) 1.3 (1.1, 1.7) 16.50*** (11.06, 24.62)
Cocaine 17.3 (13.8, 21.5) 0.9 (0.7, 1.1) 19.70*** (13.36, 29.05)
Opiates (other than heroin) 19.4 (15.7, 23.7) 2.1 (1.8, 2.5) 10.58*** (7.85–14.26)
Drug use in the past year
Marijuana 84.6 (80.0, 88.4) 27.3 (25.5, 29.1) 12.29*** (8.86, 17.06)
Ecstasy 51.7 (46.1, 57.2) 5.1 (4.5, 5.9) 17.96*** (13.63, 23.67)
Cocaine 34.6 (29.2, 40.4) 2.3 (1.9, 2.7) 22.02*** (15.84, 30.61)
Opiates (other than heroin) 44.2 (39.2, 49.3) 5.5 (4.9, 6.2) 13.00*** (9.99, 16.93)
Other risky behaviors
Drove after binge drinking 35.2 (29.4, 41.4) 9.4 (8.1, 10.8) 5.37*** (4.09, 7.04)
Passenger with a drunk driver 66.0 (60.5, 71.1) 21.3 (19.7, 23.1) 6.83*** (5.38, 8.69)
Drove after drinking 58.7 (51.6, 65.4) 26.9 (24.7, 29.2) 4.03*** (2.98, 5.45)
***P < 0.001. aThe sample sizes for logistic regression models ranged from 10 474 to 10 555 with the exception of  ‘drink to get drunk’, which was based
on only those who consumed alcohol in the past 30 days (n = 8576). bOdds ratios are also adjusted for gender, race, age, living arrangement, parental
education, fraternity/sorority membership, grade point average, geographical region, commuter status and admissions selectivity. The results for these
variables are not shown. cThe reference group for each logistic regression model was students who did not report non-medical use of  prescription stim-
ulants in the past year.
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students such as heavy episodic drinking (e.g. Cashin,
Presley & Meilman 1998; Wechsler et al. 2000;
Wechsler et al. 2002), marijuana use (e.g. Bell,
Wechsler & Johnston 1997; Gledhill-Hoyt et al. 2000),
and ecstasy use (e.g. Strote, Lee & Wechsler 2002;
Yacoubian 2003),
At least two other studies have shown that undergrad-
uate college men were more likely than women to report
non-medical use of  prescription stimulants (Johnston et
al. 2003a; McCabe et al. in press). Despite gender differ-
ences in prevalence of  non-medical use, the results of  the
present study indicated that risk factors for non-medical
use of  prescription stimulants generally operated in a sim-
ilar way for women and men. The higher rates of  non-
medical prescription stimulant use found among white
college students compared to other racial groups is con-
sistent with racial differences in non-medical use of  pre-
scription stimulants among college students (McCabe et
al. in press) as well as racial differences found in the pre-
scription rates for stimulant medications (e.g. LeFever,
Dawson & Morrow 1999; Safer & Malever 2000; Cox
et al. 2003; Zito et al. 2003; McCabe et al. in press).
Finally, the higher non-medical rates of  prescription stim-
ulants use among members of  social sororities and frater-
nities are consistent with studies that have found higher
prevalence rates of  other drug use among students who
belong to these organizations (e.g. Bell, Wechsler &
Johnston 1997; Wechsler et al. 2002; Yacoubian 2003).
Consistent with previous studies examining other
illicit drug use, the non-medical use of  prescription stim-
ulants varied across different types of  colleges and univer-
sities (Bell et al. 1997; Gledhill-Hoyt et al. 2000; Strote
et al. 2002). In the present study, the annual non-medical
use of  prescription stimulants had a wide range across
schools from zero per cent at the lowest to 25% at the
highest. The variation in non-medical use was consistent
with differences observed across previous single institu-
tion studies and reinforces the value of  collecting repre-
sentative samples from multiple colleges and universities.
The present study found similar geographical patterns of
non-medical use of  prescription stimulants, as was found
in the MTF study among young adults ages 19–30, with
the highest annual rates of  non-medical methylphenidate
use found among young adults residing in the North-
eastern region of  the United States (Johnston et al.
2003a). The high prevalence rates found among colleges
in the North-eastern region of  the United States also
resembles at least two single institution studies that
found high rates of  non-medical use of  prescription stim-
ulants at small colleges in the North-east (Babcock &
Byrne 2000; Low & Gendaszek 2002). 
Taken together, the findings that associate higher
rates of  non-medical prescription stimulant use with
more competitive admissions standards as well as frater-
nity/sorority membership suggest these factors are serv-
ing collectively as a proxy for higher socio-economic
status. Indeed, at least one study has found that under-
graduate students with higher family incomes reported
higher rates of  non-medical prescription stimulant use
(Teter et al. 2003).
The present study found that non-medical users of
prescription stimulants were dramatically more likely to
use other drugs and engage in other risky behaviors,
which is consistent with at least three other college-based
studies (Teter et al. 2003; McCabe et al. in press; Teter
et al. in press). In addition, Teter et al. in press) found the
most prevalent motivations for non-medical use of  pre-
scription stimulants among college students were to
improve concentration, enhance alertness and to get
high. Over 50% of  non-medical users reported using pre-
scription stimulants to get high and substance use rates
were significantly higher among non-medical users than
non-users, regardless of  motivation for non-medical use
(Teter et al. in press). The higher rates of  substance use
and other risky behaviors found among non-medical pre-
scription stimulant users may be an indication that the
non-medical use of  prescription stimulants is part of  a
larger cluster of  problem behaviors among college stu-
dents (Jessor, Donovan & Costa 1991).
Several anecdotal case reports document the possible
consequences of  non-medical use of  stimulants (e.g. Par-
ran & Jasinski 1991; Massello & Carpenter 1999; Barrett
& Pihl 2002). Epidemiological studies have found that a
significant proportion of  non-medical prescription stimu-
lant users develop problem use and dependence behav-
iors (Zacny et al. 2003; Simoni-Wastila & Strickler 2004).
In addition, McCabe et al. in press) found in a random
sample of  9161 undergraduate students that over 90% of
non-medical users of  prescription stimulants who
reported a source indicated they obtained prescription
stimulants from peers and friends (McCabe et al. 2004b).
In these cases, the non-medical user is likely to be
unaware of  the stimulant’s potential for interaction with
other drugs or, alternatively, the drug’s documented con-
traindications and precautions.
Limitations
The 2001 CAS did not measure legitimate medical use of
prescription stimulants or diagnosis, so it was not possi-
ble to assess how many students with legitimate prescrip-
tions for stimulants may have misused their own or
someone else’s stimulant medication. As the data were
cross-sectional, inferences about causality are limited
and we could not assess whether certain factors preceded
initiation of  non-medical use of  prescription stimulants.
Longitudinal data are needed to further examine the
directionality of  these associations. Additional research is
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needed to ascertain the behavioral patterns that lead to
the high rates of  non-medical use of  prescription stimu-
lants. Finally, the present study probably underestimates
the extent of  non-medical psychostimulant use on US col-
lege campuses because we focused exclusively on three
stimulants (e.g. Ritalin, Dexedrine or Adderall) and did
not examine the non-medical use of  other methylpheni-
date formulations (e.g. Concerta) or other dextroamphet-
amine formulations (e.g. Dextrostat).
The CAS is subject to the limitations of  self-report sur-
veys. However, such surveys have been used widely and
are considered generally valid in examining substance
use when certain conditions of  confidentiality are met
(O’Malley, Bachman & Johnston 1983; Johnston &
O’Malley 1985; Harrison & Hughes 1997; O’Malley &
Johnston 2002). For instance, it was made clear to stu-
dents in the present study that participation was volun-
tary, the relevance of  the study was explained, and
respondents were assured that their responses would
remain anonymous. Next, non-response may have intro-
duced potential bias in the present study. While we can
never fully eliminate the possibility of  bias introduced
through non-response, we tried to minimize its impact
through weighting procedures. In addition, we examined
the impact of  the response rate and found no significant
relationship between response rate and the prevalence
rates of  non-medical use of  stimulant medication. Fur-
thermore, the prevalence rates of  non-medical use of  pre-
scription stimulants reported in this study are
comparable to rates found in other national substance
use surveys of  US young adults and college students
(Johnston et al. 2003a, 2003b; Office of  Applied Studies
2002a, 2002b). Finally, the study sample consisted of
students attending 4-year US colleges and is not neces-
sarily representative of  all US college students, including
those attending 2-year colleges. Therefore, our results
may not be generalizable to the entire US college popula-
tion or university students in other countries.
Future practice
Despite their potential for abuse, prescription stimulants
remain a highly effective and safe medication for the
majority of  individuals with ADHD. At least one study
has examined the prevalence rates of  prescribed college
stimulant users being approached to divert their stimu-
lant medication (McCabe et al. in press). Of  the under-
graduate students who were medically prescribed
stimulant medication for ADHD, approximately 54% had
been approached to divert their medication (e.g. sell,
trade or give away) in the past year which was higher
than previous investigations of  secondary school stu-
dents (e.g. Musser et al. 1998; McCabe et al. 2004).
Collegiate environments present unique challenges to
implementing social control strategies compared to ele-
mentary and secondary schools because most college
students are adults who are responsible for their own
care, and parents or school officials are not as available
to provide supervision of  medications. One possible
means of  reducing diversion and abuse is the use of  novel
pharmaceutical delivery systems that are less prone to
abuse (e.g. Concerta). Additionally, appropriate diagno-
sis, treatment and therapeutic monitoring of  college stu-
dents who are receiving prescription psychostimulants is
crucial, not only to improve clinical outcomes but also to
help prevent the abuse of  these medications within a pop-
ulation that is largely responsible for their own medica-
tion management.
Future research
Given the proven therapeutic efficacy of  prescription
stimulants for the treatment of  ADHD (Goldman et al.
1998), there is a need to balance the medical necessity
of  these drugs and the risk for non-medical use among
adolescents and young adults. Future research should be
conducted to better categorize non-medical users and
examine how prescription stimulants are diverted to
non-medical use. Further research is also needed to
examine additional individual and contextual variables
that might be associated with non-medical use of  pre-
scription stimulants, such as diagnosis of  ADHD, route of
administration and motivations for non-medical use.
Finally, the present study focused exclusively on college
students within the United States. Research is needed to
examine whether the findings from this study generalize
to other countries. International work is particularly
important, as it is not known whether the higher preva-
lence rates of  ADHD and the use of  prescription psycho-
stimulants in the United States are correlated with the
increased non-medical use of  these medications. There-
fore, it is unclear if  countries outside the United States
are at less risk for the non-medical use of  prescription
stimulants.
While the national prevalence of  drinking among US
college students has remained steady for the past
decade, the non-medical use of  several prescription
drugs has increased among college students (Gledhill-
Hoyt et al. 2000; Wechsler et al. 2002; Johnston et al.
2003a; Mohler-Kuo, Lee & Wechsler 2003). The non-
medical use of  prescription medications among college
students is second only to marijuana as the most com-
mon form of  illicit drug use (Johnston et al. 2003a).
Findings from the present study provide additional sup-
port to the hypothesis that the non-medical use of  pre-
scription stimulants represents a problem within some
subgroups of  college students that needs to be addressed
with effective prevention efforts.
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